Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-07

FDA Approved: RAMELTEON — Supplemental Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

The FDA entry documents a supplemental application submission for ramelteon from Dr. Reddy's Laboratories as part of an approval action for insomnia treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)